Radboud University Medical Centre
Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant
The company is working with investigators at Radboud University to validate an RNA liquid biopsy test to better tailor therapy in advanced castration-resistant prostate cancer.
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
Written by early OGM adopters, the framework describes best practices for the technology's clinical implementation for hematological malignancies.
Pacific Biosciences, Radboud University Partner to Study Clinical Use of Long-Read Sequencing
PacBio said it will provide reagent donations and discounts to Radboud University Medical Center, as well as technical and bioinformatics expertise.